These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7879237)

  • 1. Intraglomerular cathepsin B and L activity in chronic kidney allograft rejection.
    Paczek L; Pazik J; Gradowska L; Senatorski G; Lao M; Bartlomiejczyk I; Heidland A; Rowiński W; Szmidt J
    Transplant Proc; 1995 Feb; 27(1):932-3. PubMed ID: 7879237
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraglomerular protein accumulation in chronically rejected human kidney allografts.
    Paczek L; Bartłomiejczyk I; Gradowska L; Rowiński ; Szmidt J; Gaciong Z; Lao M; Heidland A
    Transplant Proc; 1996 Dec; 28(6):3449-51. PubMed ID: 8962345
    [No Abstract]   [Full Text] [Related]  

  • 3. Human chronic kidney allograft rejection is accompanied by increased intraglomerular cathepsin B and L activity.
    Paczek L; Pazik J; Teschner M; Schaefer RM; Rowinski W; Szmidt J; Lao M; Abgarowicz K; Gradowska L; Morzycka-Michalik M; Heidland A
    Transpl Int; 1994; 7 Suppl 1():S311-3. PubMed ID: 11271236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraglomerular fibronectin and laminin turn-over in chronically rejected kidney allografts in humans.
    Paczek L; Bartłomiejczyk I; Gradowska L; Szmidt J; Rowiński W; Gaciong Z; Heidland A; Laskowska-Klita T
    Ann Transplant; 1996; 1(1):41-3. PubMed ID: 9869936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma: no evidence for dysregulated proteolytic balance.
    Jung K; Friedrich B; Türk I; Roigas J; Lein M; Schnorr D; Loening SA
    J Cancer Res Clin Oncol; 1998 Jan; 124(1):60-1. PubMed ID: 9498837
    [No Abstract]   [Full Text] [Related]  

  • 6. Human kidney cathepsins B and L. Characterization and potential role in degradation of glomerular basement membrane.
    Baricos WH; Zhou Y; Mason RW; Barrett AJ
    Biochem J; 1988 May; 252(1):301-4. PubMed ID: 2844149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of cathepsins B, H, L and kininogen in breast cancer patients.
    Gabrijelcic D; Svetic B; Spaić D; Skrk J; Budihna J; Turk V
    Agents Actions Suppl; 1992; 38 ( Pt 2)():350-7. PubMed ID: 1334335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variation in activity of kidney and liver cysteine cathepsins].
    Zhloba AA; Dubikăitis AIu
    Biull Eksp Biol Med; 1995 Dec; 120(12):586-9. PubMed ID: 8834207
    [No Abstract]   [Full Text] [Related]  

  • 9. Physical association of Ras and cathepsins B and L in the conditioned medium of v-Ha-ras-transformed NIH3T3 cells.
    Hiwasa T; Kominami E
    Biochem Biophys Res Commun; 1995 Nov; 216(3):828-34. PubMed ID: 7488200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues.
    Nakanishi H; Tominaga K; Amano T; Hirotsu I; Inoue T; Yamamoto K
    Exp Neurol; 1994 Mar; 126(1):119-28. PubMed ID: 8157122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential secretion of cathepsins B and L from normal and tumor human lung cells stimulated by 12(S)-hydroxy-eicosatetraenoic acid.
    Ulbricht B; Hagmann W; Ebert W; Spiess E
    Exp Cell Res; 1996 Aug; 226(2):255-63. PubMed ID: 8806429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin B, Cathepsin H, and cathepsin L.
    Barrett AJ; Kirschke H
    Methods Enzymol; 1981; 80 Pt C():535-61. PubMed ID: 7043200
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphine modulates cathepsin B and L activity in isolated glomeruli and mesangial cells.
    Singhal PC; Sagar S; Gibbons N
    Inflammation; 1995 Feb; 19(1):67-73. PubMed ID: 7705887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of renal mass on chronic kidney allograft rejection in rats.
    Heemann UW; Azuma H; Tullius SG; Mackenzie HS; Schmid C; Brenner BM; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):549. PubMed ID: 7879094
    [No Abstract]   [Full Text] [Related]  

  • 15. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters.
    Adenis A; Huet G; Zerimech F; Hecquet B; Balduyck M; Peyrat JP
    Cancer Lett; 1995 Sep; 96(2):267-75. PubMed ID: 7585467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic criteria of chronic renal allograft rejection.
    Mihatsch MJ; Nickeleit V; Gudat F
    Transplant Proc; 1999; 31(1-2):1295-7. PubMed ID: 10083578
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.
    Klose A; Zigrino P; Dennhöfer R; Mauch C; Hunzelmann N
    Anal Biochem; 2006 Jun; 353(1):57-62. PubMed ID: 16620747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cathepsin B and L in anti-glomerular basement membrane nephritis in rats.
    Baricos WH; Shah SV
    Ren Physiol Biochem; 1989; 12(5-6):400-5. PubMed ID: 2623352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein restriction influences glomerular matrix turnover and tubular hypertrophy by modulation of renal proteinase activities.
    Schaefer L; Meier K; Häfner C; Teschner M; Heidland A; Schaefer RM
    Miner Electrolyte Metab; 1996; 22(1-3):162-7. PubMed ID: 8676812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validity of Banff grading of chronic rejection in renal transplantation.
    Oh CK; Jeong HJ; Kim YS; Kim MS; Choi KH; Lee HY; Han DS; Park K
    Transplant Proc; 1996 Jun; 28(3):1441-2. PubMed ID: 8658731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.